[Gemcitabine in the chemoradiotherapy for locally advanced pancreatic cancer: a meta-analysis].
Gray Institute for Radiation Oncology & Biology, University of Oxford, Oxford, UK. thomas.brunner@oncology.ox.ac.uk
T
T
Brunner